Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1637 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

FMC Q1 Revenue Surges

FMC has posted a net income of $80.4m for the first quarter of 2010, compared to $70.9m, for the prior year period. Income from operations was $135.9m, compared

Siogen, Veeda Partner To Develop Doxorubicin

Doxorubicin is a drug which is used in chemotherapy for the treatment of leukemias, lymphomas and other cancers. Encapsulation of Doxorubicin in Siosomes is designed to increase efficacy